To view this email as a web page, click here.
 
FDA adds warning to Xeljanz
FDA is adding an important new Boxed Warning on the higher dose version of this drug.
Read more
 
FDA approves first sensor-enabled inhaler
Asthma patients may soon treat themselves with first-ever digital maintenance inhaler.
Read more
 
EpiPen shortage: pharma maker, retailer offer aid
EpiPens have been in short supply, but stakeholders are trying to fill in the access gap.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.